ArticleThoracic cancer2022

Anti-PD1 or anti-PD-L1 antibodies alone or in combination with chemotherapy first-line treatment of advanced non-small cell lung cancer.

Xuexia Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.